SCA
DCPH

Secor Capital Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Secor Capital Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,428
Closed -$451K – 294
2019
Q1 		$451K Buy
19,428
+7,382
+61% +$193K 0.09% 288
2018
Q4 		$253K Buy
+12,046
New +$296K 0.03% 394

Other funds holding DCPH

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Secor Capital Advisors's DCPH Position: Q2 2019 in Review

Secor Capital Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2019, closing a stake of 19,428 shares — an estimated $451K sold.

Secor Capital Advisors first reported a position in DCPH in Q4 2018 and held it in 2 quarters. The position peaked at $451K in Q1 2019. 85 funds tracked by Wall St. Rank hold DCPH as of Q2 2019.

  • Secor Capital Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Secor Capital Advisors sold 19,428 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2019, an estimated $451K.
  • Secor Capital Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Secor Capital Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $451K in Q1 2019.
  • 85 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2019.

Based on Secor Capital Advisors's 13F filing for Q2 2019.